-+ 0.00%
-+ 0.00%
-+ 0.00%
Pila Pharma attends Bio Europe to advance partnership talks
Share
Listen to the news
Pila Pharma attends Bio Europe to advance partnership talks
  • Pila Pharma will attend Bio Europe in Cologne on November 9-11, 2026, to advance pharmaceutical partnership discussions.
  • CEO Gustav H. Gram will meet existing and potential partners about XEN-D0501, its oral obesity candidate currently in the PP-CT04 trial.
  • Planned meetings will also explore pain treatment opportunities, including erythromelalgia, for which XEN-D0501 holds US FDA orphan drug designation.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pila Pharma AB published the original content used to generate this news brief on November 02, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending